Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

neuroendocrine tumor

  • You have access
    Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of 177Lu-DOTA-EB-TATE
    Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu and Xiaoyuan Chen
    Journal of Nuclear Medicine March 1, 2021, 62 (3) 386-392; DOI: https://doi.org/10.2967/jnumed.120.248658
  • You have access
    A Prospective Randomized, Double-blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-differentiated Neuroendocrine Tumors
    li huo, Wenjia Zhu, Yuejuan Cheng, Ru Jia, Hong Zhao, Chunmei Bai, Jianming Xu and Shaobo Yao
    Journal of Nuclear Medicine February 12, 2021, jnumed.120.253096; DOI: https://doi.org/10.2967/jnumed.120.253096
  • Open Access
    Dual Positron Emission Tomography imaging in bronchial neuroendocrine neoplasms (NENs): The NETPET score as a prognostic biomarker
    David L Chan, Gary A Ulaner, David A. Pattison, David Wyld, Rahul Ladwa, Julian Kirchner, Bob T Li, W. Victoria Lai, Nick Pavlakis, PAUL J ROACH and Dale L. Bailey
    Journal of Nuclear Medicine February 12, 2021, jnumed.120.257659; DOI: https://doi.org/10.2967/jnumed.120.257659
  • You have access
    Effects of Repeated 131I-meta-iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activities in Patients with Metastatic Neuroendocrine Tumors
    Keiichiro Yoshinaga, Takashige Abe, Shozo Okamoto, Yuko Uchiyama, Osamu Manabe, Yoichi M. Ito, Naomi Tamura, Natsue Ito, Naho Yoshioka, Komei Washino, Nobuo Shinohara, Nagara Tamaki and Tohru Shiga
    Journal of Nuclear Medicine October 16, 2020, jnumed.120.250803; DOI: https://doi.org/10.2967/jnumed.120.250803
  • You have access
    High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
    Rudolf A. Werner, Thorsten Derlin, Steven P. Rowe, Lena Bundschuh, Gabriel T. Sheikh, Martin G. Pomper, Sebastian Schulz, Takahiro Higuchi, Andreas K. Buck, Frank M. Bengel, Ralph A. Bundschuh and Constantin Lapa
    Journal of Nuclear Medicine August 28, 2020, jnumed.120.245464; DOI: https://doi.org/10.2967/jnumed.120.245464
  • You have access
    Head-to-Head Comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study
    Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Chunmei Bai, Hong Zhao, Ru Jia, Jianming Xu and Li Huo
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 897-903; DOI: https://doi.org/10.2967/jnumed.119.235093
  • You have access
    The Academic NDA: Justification, Process, and Lessons Learned
    John J. Sunderland
    Journal of Nuclear Medicine April 1, 2020, 61 (4) 480-487; DOI: https://doi.org/10.2967/jnumed.119.238287
  • You have access
    Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE
    Thomas L. Andersen, Christina Baun, Birgitte B. Olsen, Johan H. Dam and Helge Thisgaard
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 228-233; DOI: https://doi.org/10.2967/jnumed.119.233015
  • You have access
    A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on 68Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors
    Anni Gålne, Helen Almquist, Martin Almquist, Cecilia Hindorf, Tomas Ohlsson, Erik Nordenström, Anna Sundlöv and Elin Trägårdh
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1717-1723; DOI: https://doi.org/10.2967/jnumed.119.226332
  • You have access
    Parameters to Predict Progression-Free and Overall Survival After Peptide Receptor Radionuclide Therapy: A Multivariate Analysis in 782 Patients
    Else A. Aalbersberg, Daphne M.V. Huizing, Iris Walraven, Berlinda J. de Wit-van der Veen, Harshad R. Kulkarni, Aviral Singh, Marcel P.M. Stokkel and Richard P. Baum
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1259-1265; DOI: https://doi.org/10.2967/jnumed.118.224386

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire